THOMAS C. CHEN - 21 May 2025 Form 4 Insider Report for NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)

Signature
/S/ THOMAS C CHEN
Issuer symbol
NTHI
Transactions as of
21 May 2025
Transactions value $
$40,002
Form type
4
Filing time
23 May 2025, 21:30:24 UTC
Previous filing
19 May 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
CHEN THOMAS C CEO, Director, 10%+ Owner 23975 SORRENTO PARK, SUITE 205, CALABASAS /S/ THOMAS C CHEN 19 May 2025 0001998682

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTHI Common Stock Purchase $20K +2.76K +0.51% $7.25 549K 21 May 2025 Direct F1, F2, F3
transaction NTHI Common Stock Purchase $20K +2.71K +0.49% $7.38 552K 22 May 2025 Direct F1, F3, F4
holding NTHI Common Stock 261K 21 May 2025 By HCWG LLC. F5
holding NTHI Common Stock 888K 21 May 2025 By NeuCen Biomedical Co. Ltd. F6
holding NTHI Common Stock 2.83M 21 May 2025 By TR Chen Third Family Limited Partnership. F7
holding NTHI Common Stock 93.3K 21 May 2025 By Tien Duan Chen Trust.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The aggregate number of shares of Issuer's Class A common stock (the "Shares") purchased by the Reporting Person on the same day at different prices.
F2 Represents the weighted average purchase price. The Shares were purchased at prices ranging from $7.181 to $7.25 per share, inclusive. Full information regarding the number of Shares sold at each price shall be provided to the Securities and Exchange Commission staff, Issuer or any security holder, upon request.
F3 Includes shares of common stock held by certain members of Reporting Person's immediate family of which Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest, if any, therein.
F4 Represents the weighted average purchase price. The Shares were purchased at prices ranging from $7.38 to $7.4899 per share. Full information regarding the number of Shares sold at each price shall be provided to the Securities and Exchange Commission staff, Issuer or any security holder, upon request.
F5 Such shares represent only Reporting Person's percentage interest in HCWG LLC.
F6 Shares held by NeuCen Biomedical Co. Ltd. ("NeuCen"). NeuCen is owned in part by Reporting Person's spouse. Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein.
F7 Shares held by T. R. Chen Third Family Limited Partnership, a NV limited partnership, of which Reporting Person and his spouse are the general partners with sole voting and dispositive power. Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein.